Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00156143
Status:
COMPLETED
Last Update Posted:
2007-07-30
First Post:
2005-09-07
Brief Title:
Transition Study Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
GH Therapy in Partial GHD Adolescents Evaluation of Efficacy Based on Body Composition and Comparison of 2 Different Doses of Genotonorm Open-Label Randomised Comparative Controlled Parallel-Group Multi-Center Phase IIIB Clinical Trial
Status:
COMPLETED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TAUBER
Brief Summary:
To evaluate in boys and girls the improvement in body composition under GH treatment in adolescents with CO-GHD who remain partially GHD after GH discontinuation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A6281018 | None | None | None |